ORIGINAL RESEARCH article
Front. Hum. Dyn.
Sec. Environment, Politics and Society
Volume 7 - 2025 | doi: 10.3389/fhumd.2025.1539009
This article is part of the Research TopicAsian Medical Industries: Beyond Tradition, Beyond Medicine, Beyond AsiaView all 3 articles
Lifestyle as cause and market: NCDs and Ayurveda care in Africa
Provisionally accepted- Athena Institute, Faculty of Science, VU Amsterdam, Amsterdam, Netherlands
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In this paper, I explore how the Indian Ocean is (re-)emerging as a region in the medical practice I have been following -new flows of Ayurvedic medicines from India to East Africa -not only as a trade route on the transoceanic axis between India and Africa, but also as a "shared world in turmoil" in which the Indian diaspora, the Indian pharmaceutical industry, and Ayurvedic practitioners are creating new "lifestyle disease markets". India-based pharmaceutical entrepreneurs from The Himalaya Drug Company and Charak Pharmaka are the most prominent distributors of Ayurvedic pharmaceuticals, extending their reach into Kenya through travel and Indo-African partnerships. Ayurvedic practitioners, most of whom are of Indian origin and born in Kenya, as well as Kenyan therapists, also play an important role. Their aspirations and efforts include the promotion of Ayurveda care in a variety of settings, from upscale Ayurvedic clinics to pharmacies and even slums. The "ancient Ayurveda tradition" promises to be a viable way to address the alarming rise of chronic non-communicable diseases (NCDs) on the continent, such as diabetes, cancer, cardiovascular disease and mental disease, diseases often referred to as "lifestyle diseases". The choice of terminology suggests both agency and privilege; implying that their prevention, control, and management are amenable to behavioural change related to consumption patterns, diet, physical activity, and the use of Ayurvedic medicines. Using NCDs in Kenya as a case study, I shed light on the transformation of the Ayurvedic industry and new transnational pharmaceutical circuits by a) interrogating how formerly localized Ayurvedic producers and practitioners have become transnational entrepreneurs, strategically reinventing and tailoring Ayurveda care as an "alternative modernity" for "modern" NCDs, and b) critically exploring for which patients the attainment of a "wholesome lifestyle" and health consciousness is possible in the context of patchy chronic care infrastructure. I will provide an analysis that situates people's healing perceptions and therapists' practices within a field of possibilities shaped by health policies, the burgeoning burden of chronic disease, new market dynamics, and life conditions.
Keywords: NCDS, Ayurveda, Kenya, Lifestyle disease, Pharmaceuticalization
Received: 03 Dec 2024; Accepted: 05 Jun 2025.
Copyright: © 2025 Meier zu Biesen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Caroline Meier zu Biesen, Athena Institute, Faculty of Science, VU Amsterdam, Amsterdam, Netherlands
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.